Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Article number3003
JournalJournal of Clinical Oncology
Volume38
Issue number15
DOIs
Publication statusPublished - 2020

Cite this